pharmerica posts
FeedPosted Feb 17th 2008 4:40PM by Trey Thoelcke (RSS feed)
Filed under: Earnings reports
Even though tomorrow is a holiday in the U.S., there are a handful of companies planning to report quarterly earnings nonetheless. Perhaps some may be trying to keep a low profile; others may simply not be concerned with the American holiday schedule. Regardless, here's a quick peek at some of those companies, with the consensus earnings per share estimate of analysts surveyed by Thomson Financial compared to the previous quarter and year-ago quarter, the share price at the close on Friday (with charts behind the links), and consensus recommedations.
UPDATED: Constellation reported .13 EPS; Flagstone reported .60 EPS; Natco reported .66 EPS; PharMerica reported .09 EPS; Stewart reported -1.74 EPS; and Trico Marine reported 2.08 EPS.
Posted Sep 7th 2007 11:10AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Chicago Merc Exch Hld'A' (CME), NYSE Euronext (NYX), Analyst initiations
MOST NOTEWORTHY: The exchange sector, Progenics Pharma, Tyco Electronics and PharMerica were today's noteworthy initiations:
- Keefe Bruyette initiated coverage on Exchange Sector: The firm started shares of CME Group Inc (NYSE: CME), NYMEX Holdings Inc (NYSE: NMX) and NYSE Euronext Inc (NYSE: NYX) with Outperform ratings and a $669 target, $147 target and $90 target, respectively. The firm also started shares of Investment Technology Group (NYSE: ITG), Nasdaq Stock Market Inc (NASDAQ: NDAQ) and IntercontinentalExchange Inc (NYSE: ICE) with Underperform ratings and a $47 target, $36 target and $158 target, respectively, and shares of Knight Capital Group (NASDAQ: NITE) with an Underperform rating and $13 target.
- Progenics Pharmaceuticals (NASDAQ: PGNX) was added to Friedman Billings' Top Picks list and its Outperform rating was maintained. The firm has a high degree of confidence in the success of the MNTX Ph III studies in post-operative ilieus, as well as the FDA approval of the subcutaneous injection in terminally ill patients with opiod-induced constipation around the 1/31/07 PDUFA date.
- RBC believes margin expansion will drive long-term appreciation in Tyco Electronics Ltd (NYSE: TEL) and started shares with an Outperform rating and $41 target.
- PharMerica Corporation (NYSE: PMC) was initiated with an Underperform rating at Bear Stearns. The firm believes PMC will be pressured by customer losses and generic reimbursement cuts and sees shares trading in $12-$13 range.
OTHER INITIATIONS:
Posted Aug 14th 2007 11:35AM by Kevin Shult (RSS feed)
Filed under: Before the bell, Analyst reports, , Analyst initiations, Stocks to Buy, Stocks to Sell
MOST NOTEWORTHY: MoneyGram (MGI), F5 Networks (FFIV), ARK Restaurants (ARKR), Nara Bancorp (NARA) and St. Jude Medical (STJ) were today's noteworthy initiations:
- AG Edwards initiated MoneyGram (NYSE: MGI) with a Buy rating because it believes the recent pullback in the shares provides an attractive entry point; Stephens started shares of MoneyGram with an Overweight rating, and believes the company is well positioned to create strong transactional growth and take market share.
- CIBC expects F5 Networks (NASDAQ: FFIV) to benefit from strong fundamentals in application networking solutions and started shares with a Sector Outperformer rating and $85 target.
- Morgan Joseph initiated ARK Restaurants (NASDAQ: ARKR) with a Buy rating and $43 target; they believe ARK is well positioned to benefit from strong SSS & earnings leverage given its strong store locations, wide ranging price points, and stable unit development pipeline.
- Sandler is positive on Nara Bancorp (NASDAQ: NARA), starting shares with a Buy rating and $17 target, based on the company's long-term prospects.
- ThinkEquity believes St. Jude Medical (NYSE: STJ) is poised to take market share in the ICD markets and started shares with a Buy rating and $56 target...
OTHER INITIATIONS:
- Banc of America initiated PharMerica (NYSE: PMC) with a Buy rating and $18 target.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required). Posted Jul 26th 2007 12:45PM by Kevin Shult (RSS feed)
Filed under: Analyst reports, Alcoa Inc (AA), Analyst initiations, Polo Ralph Lauren'A' (RL)
MOST NOTEWORTHY: Polo Ralph Lauren (RL), Alcan (AL), Alcoa (AA) and Conn's, Inc (CONN) were today's noteworthy initiations:
- Polo Ralph Lauren (NYSE: RL) was initiated with a Market Perform rating at Piper Jaffray. The firm feels the risk/reward is balanced at current levels given the near-term risks from increased investment and exposure to inconsistent U.S. wholesale markets.
- Goldman Sachs resumed coverage of Alcan (NYSE: AL) and Alcoa (NYSE: AA) with Neutral ratings and a $101 target and $48 target, respectively.
- Morgan Joseph is positive on Conn's Inc's (NASDAQ: CONN) strong track record of growth, new store growth and easy comps, and initiated shares with a Buy rating and $34 target.
OTHER INITIATIONS:
- Stifel initiated shares of Pharmerica (NASDAQ: PMC) with a Hold rating on valuation.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).